AtriCure CSO Sells 5,000 Shares — A Modest Trim or a Pattern Worth Watching? [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
Doraiswamy Vinayak, Chief Scientific Officer of AtriCure (NASDAQ:ATRC) , reported the sale of 5,000 shares of common stock in an open-market transaction on March 12, 2026, according to a SEC Form 4 filing Transaction summary Metric Value Shares sold (direct) Transaction value Post-transaction shares (direct) Post-transaction value (direct ownership) $2.86 million Transaction value based on SEC Form 4 reported price ($29.83); post-transaction value based on March 12, 2026 market close ($29.54). Key questions How does this transaction compare to Vinayak's prior selling activity? The March transaction is the largest sale by Vinayak in the past year, exceeding his prior two sell transactions of 2,500 shares each (in May and August 2025), and represents a larger single reduction in holdings. What was the market context during the transaction? Shares of AtriCure were priced at $29.83 per share at the time of the transaction; the company's one-year total return s
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure CFO Sees 12%-14% Organic Growth in 2026 as Pain Management Adoption Accelerates [Yahoo! Finance]Yahoo! Finance
- AtriCure to Participate in the Citizens Life Sciences Conference [Yahoo! Finance]Yahoo! Finance
- AtriCure to Participate in the Citizens Life Sciences ConferenceBusiness Wire
- AtriCure (NASDAQ:ATRC) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- AtriCure (NASDAQ:ATRC) was given a new $53.00 price target on by analysts at Canaccord Genuity Group Inc..MarketBeat
ATRC
Earnings
- 2/17/26 - Beat
ATRC
Sec Filings
- 3/16/26 - Form 4
- 3/12/26 - Form 144
- 3/12/26 - Form 4
- ATRC's page on the SEC website